DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+18.6%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.69B
AUM Growth
+$682M
(+11%)
Cap. Flow
-$874M
Cap. Flow
% of AUM
-13.05%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
681
New
246
Increased
85
Reduced
72
Closed
235
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
+$72.1M |
| 2 |
Indivior
INDV
|
+$49.7M |
| 3 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
+$45.7M |
| 4 |
Merus
MRUS
|
+$32.9M |
| 5 |
Viatris
VTRS
|
+$30.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$102M |
| 2 |
Surgery Partners
SGRY
|
+$94.4M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
+$57.6M |
| 4 |
BioNTech
BNTX
|
+$49.8M |
| 5 |
Integra LifeSciences
IART
|
+$42.8M |
Sector Composition
| 1 | Healthcare | 87.45% |
| 2 | Industrials | 0.72% |
| 3 | Technology | 0.55% |
| 4 | Financials | 0.42% |
| 5 | Consumer Discretionary | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
PNC Financial Services
PNC
$80.2B
| $288K | ﹤0.01% |
1,559
-3,731
| -71% | -$690K |
|
377
CEVA Inc
CEVA
$555M
| $288K | ﹤0.01% |
+11,915
| New | +$288K |
|
|
UCB
378
United Community Banks, Inc.
UCB
$4.02B
| $285K | ﹤0.01% |
+9,800
| New | +$285K |
|
379
Imperial Oil
IMO
$44.5B
| $284K | ﹤0.01% |
+4,027
| New | +$284K |
|
380
Warner Bros
WBD
$30.6B
| $281K | ﹤0.01% |
34,113
-75,712
| -69% | -$625K |
|
381
Woodward
WWD
$14.4B
| $280K | ﹤0.01% |
1,632
-16
| -1% | -$2.74K |
|
382
UWM Holdings
UWMC
$1.41B
| $277K | ﹤0.01% |
+32,544
| New | +$277K |
|
383
The Ensign Group
ENSG
$10B
| $277K | ﹤0.01% |
+1,927
| New | +$277K |
|
384
RTX Corp
RTX
$206B
| $277K | ﹤0.01% |
+2,285
| New | +$277K |
|
385
QuantumScape
QS
$5.37B
| $275K | ﹤0.01% |
+47,893
| New | +$275K |
|
386
SS&C Technologies
SSNC
$21.7B
| $275K | ﹤0.01% |
+3,704
| New | +$275K |
|
387
ASGN Inc
ASGN
$2.3B
| $271K | ﹤0.01% |
+2,911
| New | +$271K |
|
388
Ryan Specialty Holdings
RYAN
$6.93B
| $271K | ﹤0.01% |
+4,082
| New | +$271K |
|
389
TG Therapeutics
TGTX
$5.14B
| $268K | ﹤0.01% |
+11,478
| New | +$268K |
|
390
Merit Medical Systems
MMSI
$5.47B
| $267K | ﹤0.01% |
+2,697
| New | +$267K |
|
391
Targa Resources
TRGP
$34.5B
| $263K | ﹤0.01% |
1,776
-3,618
| -67% | -$536K |
|
392
V2X
VVX
$1.76B
| $259K | ﹤0.01% |
+4,639
| New | +$259K |
|
393
CACI
CACI
$10.4B
| $258K | ﹤0.01% |
512
-1,016
| -66% | -$513K |
|
394
XPO
XPO
$15.6B
| $257K | ﹤0.01% |
+2,386
| New | +$257K |
|
395
Glaukos
GKOS
$5.27B
| $252K | ﹤0.01% |
+1,938
| New | +$252K |
|
396
America's Car Mart
CRMT
$297M
| $251K | ﹤0.01% |
5,979
-16,288
| -73% | -$683K |
|
397
Mettler-Toledo International
MTD
$27.1B
| $247K | ﹤0.01% |
+165
| New | +$247K |
|
398
Lexicon Pharmaceuticals
LXRX
$392M
| $246K | ﹤0.01% |
+156,860
| New | +$246K |
|
399
Dynavax Technologies
DVAX
$1.14B
| $240K | ﹤0.01% |
+21,560
| New | +$240K |
|
400
Xponential Fitness
XPOF
$305M
| $239K | ﹤0.01% |
+19,255
| New | +$239K |
|